Collegium Pharmaceutical Inc (COLL)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 129.62M | 144.77M | 135.55M | 136.71M | 149.75M | 144.92M | 145.28M | 159.3M |
Operating Income | 11.76M | 24.63M | 35.63M | 45.01M | 61.69M | 49.47M | 47.47M | 34.84M |
Pre Tax Income | -7.79M | -17.56M | 17.8M | 28.78M | 46.71M | 36.62M | 29.1M | 15.58M |
Net Income | -7.2M | -17.43M | 13.01M | 20.63M | 31.94M | 27.71M | 19.61M | 9.34M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 11.76M | 24.63M | 35.63M | 45.01M | 61.69M | 49.47M | 47.47M | 34.84M |
EBITDA | 54.86M | 62.91M | 73.99M | 82.17M | 97.15M | 84.91M | 82.94M | 76.59M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.71M | 28.48M | 280.41M | 296.7M | 310.02M | 276.87M | 463.93M | 566.77M |
Operating Income | -94.08M | -75.45M | -20.69M | -23.75M | 56.23M | 17.63M | 33.32M | 166.96M |
Pre Tax Income | -94.18M | -74.87M | -39.13M | -22.72M | 27.58M | -3.37M | -28.85M | 75.73M |
Net Income | -94.18M | -74.87M | -39.13M | -22.72M | 26.75M | 71.52M | -25M | 48.16M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -3.207 | -2.284 | -1.176 | -0.675 | 0.773 | 1.997 | -0.739 | 1.477 |
EBIT | -94.08M | -75.45M | -20.69M | -23.75M | 56.23M | 17.63M | 33.32M | 166.96M |
EBITDA | -93.43M | -73.27M | 90.22M | -8.27M | 117.78M | 86.55M | 172.26M | 316.22M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.